Cargando…
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol
OBJECTIVES: a. 1. Death. 2. Acute Myocardial Infarction [AMI]. 3. Objectively confirmed, symptomatic arterial or venous thromboembolism [TE]. 4. a. Continuous Positive Airway Pressure (Cpap) or Non-Invasive Ventilation (NIV) or b. IMV in patients who at randomisation were receiving standard oxygen t...
Autores principales: | Marietta, Marco, Vandelli, Paola, Mighali, Pasquale, Vicini, Roberto, Coluccio, Valeria, D’Amico, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316577/ https://www.ncbi.nlm.nih.gov/pubmed/32586394 http://dx.doi.org/10.1186/s13063-020-04475-z |
Ejemplares similares
-
COVID-19, coagulopathy and venous thromboembolism: more questions than answers
por: Marietta, Marco, et al.
Publicado: (2020) -
Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial
por: Busani, Stefano, et al.
Publicado: (2020) -
Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19
por: Martinelli, Ida, et al.
Publicado: (2021) -
Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia
por: Costanzo, Luca, et al.
Publicado: (2020) -
A Case of COVID-19 Related Coagulopathy Complications and Heparin Resistance
por: Chowdhry, Erum, et al.
Publicado: (2021)